nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—ABCB1—Sorafenib—liver cancer	0.0946	0.32	CbGbCtD
Fexofenadine—CYP2D6—Sorafenib—liver cancer	0.0892	0.302	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—liver cancer	0.0574	0.194	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—liver cancer	0.0541	0.183	CbGbCtD
Fexofenadine—Rhinorrhoea—Sorafenib—liver cancer	0.0118	0.0461	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Sorafenib—liver cancer	0.00768	0.0299	CcSEcCtD
Fexofenadine—Pain in extremity—Sorafenib—liver cancer	0.00697	0.0271	CcSEcCtD
Fexofenadine—Nasopharyngitis—Sorafenib—liver cancer	0.00623	0.0243	CcSEcCtD
Fexofenadine—Abdominal discomfort—Sorafenib—liver cancer	0.00577	0.0225	CcSEcCtD
Fexofenadine—Epistaxis—Sorafenib—liver cancer	0.00506	0.0197	CcSEcCtD
Fexofenadine—Otitis media—Epirubicin—liver cancer	0.00456	0.0177	CcSEcCtD
Fexofenadine—Flushing—Sorafenib—liver cancer	0.00447	0.0174	CcSEcCtD
Fexofenadine—Otitis media—Doxorubicin—liver cancer	0.00422	0.0164	CcSEcCtD
Fexofenadine—Viral infection—Epirubicin—liver cancer	0.00393	0.0153	CcSEcCtD
Fexofenadine—Angioedema—Sorafenib—liver cancer	0.00383	0.0149	CcSEcCtD
Fexofenadine—Cough—Sorafenib—liver cancer	0.00366	0.0143	CcSEcCtD
Fexofenadine—Viral infection—Doxorubicin—liver cancer	0.00363	0.0142	CcSEcCtD
Fexofenadine—Myalgia—Sorafenib—liver cancer	0.00357	0.0139	CcSEcCtD
Fexofenadine—Dry mouth—Sorafenib—liver cancer	0.00349	0.0136	CcSEcCtD
Fexofenadine—Anaphylactic shock—Sorafenib—liver cancer	0.00342	0.0133	CcSEcCtD
Fexofenadine—Infection—Sorafenib—liver cancer	0.0034	0.0133	CcSEcCtD
Fexofenadine—Dry eye—Epirubicin—liver cancer	0.00328	0.0128	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00312	0.0122	CcSEcCtD
Fexofenadine—Dyspnoea—Sorafenib—liver cancer	0.00305	0.0119	CcSEcCtD
Fexofenadine—Dry eye—Doxorubicin—liver cancer	0.00303	0.0118	CcSEcCtD
Fexofenadine—Dyspepsia—Sorafenib—liver cancer	0.00301	0.0117	CcSEcCtD
Fexofenadine—Fatigue—Sorafenib—liver cancer	0.00295	0.0115	CcSEcCtD
Fexofenadine—Pain—Sorafenib—liver cancer	0.00293	0.0114	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Epirubicin—liver cancer	0.00284	0.0111	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Sorafenib—liver cancer	0.0028	0.0109	CcSEcCtD
Fexofenadine—Increased appetite—Epirubicin—liver cancer	0.00274	0.0107	CcSEcCtD
Fexofenadine—Urticaria—Sorafenib—liver cancer	0.00272	0.0106	CcSEcCtD
Fexofenadine—Body temperature increased—Sorafenib—liver cancer	0.00271	0.0105	CcSEcCtD
Fexofenadine—Abdominal pain—Sorafenib—liver cancer	0.00271	0.0105	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Doxorubicin—liver cancer	0.00263	0.0102	CcSEcCtD
Fexofenadine—Pain in extremity—Epirubicin—liver cancer	0.00257	0.01	CcSEcCtD
Fexofenadine—Increased appetite—Doxorubicin—liver cancer	0.00254	0.00988	CcSEcCtD
Fexofenadine—Hypersensitivity—Sorafenib—liver cancer	0.00252	0.00983	CcSEcCtD
Fexofenadine—Asthenia—Sorafenib—liver cancer	0.00246	0.00957	CcSEcCtD
Fexofenadine—Pruritus—Sorafenib—liver cancer	0.00242	0.00944	CcSEcCtD
Fexofenadine—Pain in extremity—Doxorubicin—liver cancer	0.00238	0.00928	CcSEcCtD
Fexofenadine—Diarrhoea—Sorafenib—liver cancer	0.00234	0.00913	CcSEcCtD
Fexofenadine—Nasopharyngitis—Epirubicin—liver cancer	0.0023	0.00897	CcSEcCtD
Fexofenadine—Dizziness—Sorafenib—liver cancer	0.00226	0.00882	CcSEcCtD
Fexofenadine—Vomiting—Sorafenib—liver cancer	0.00218	0.00848	CcSEcCtD
Fexofenadine—Rash—Sorafenib—liver cancer	0.00216	0.00841	CcSEcCtD
Fexofenadine—Dermatitis—Sorafenib—liver cancer	0.00216	0.0084	CcSEcCtD
Fexofenadine—Headache—Sorafenib—liver cancer	0.00215	0.00836	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—liver cancer	0.00213	0.0083	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Epirubicin—liver cancer	0.00207	0.00806	CcSEcCtD
Fexofenadine—Pollakiuria—Epirubicin—liver cancer	0.00206	0.00801	CcSEcCtD
Fexofenadine—Nausea—Sorafenib—liver cancer	0.00203	0.00792	CcSEcCtD
Fexofenadine—Drowsiness—Epirubicin—liver cancer	0.00198	0.00773	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00191	0.00745	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—liver cancer	0.0019	0.00741	CcSEcCtD
Fexofenadine—Epistaxis—Epirubicin—liver cancer	0.00187	0.00729	CcSEcCtD
Fexofenadine—Sinusitis—Epirubicin—liver cancer	0.00186	0.00725	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—liver cancer	0.00184	0.00715	CcSEcCtD
Fexofenadine—Epistaxis—Doxorubicin—liver cancer	0.00173	0.00675	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—liver cancer	0.00172	0.00671	CcSEcCtD
Fexofenadine—Flushing—Epirubicin—liver cancer	0.00165	0.00644	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—liver cancer	0.00153	0.00596	CcSEcCtD
Fexofenadine—Flatulence—Epirubicin—liver cancer	0.00153	0.00595	CcSEcCtD
Fexofenadine—Tension—Epirubicin—liver cancer	0.00152	0.00593	CcSEcCtD
Fexofenadine—Nervousness—Epirubicin—liver cancer	0.00151	0.00587	CcSEcCtD
Fexofenadine—Back pain—Epirubicin—liver cancer	0.0015	0.00584	CcSEcCtD
Fexofenadine—Vision blurred—Epirubicin—liver cancer	0.00146	0.00569	CcSEcCtD
Fexofenadine—Agitation—Epirubicin—liver cancer	0.00142	0.00555	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—liver cancer	0.00141	0.00551	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—liver cancer	0.00141	0.00548	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—liver cancer	0.00139	0.00543	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—liver cancer	0.00139	0.00541	CcSEcCtD
Fexofenadine—Palpitations—Epirubicin—liver cancer	0.00137	0.00534	CcSEcCtD
Fexofenadine—Cough—Epirubicin—liver cancer	0.00135	0.00527	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—liver cancer	0.00135	0.00527	CcSEcCtD
Fexofenadine—Myalgia—Epirubicin—liver cancer	0.00132	0.00514	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—liver cancer	0.00132	0.00514	CcSEcCtD
Fexofenadine—Dry mouth—Epirubicin—liver cancer	0.00129	0.00503	CcSEcCtD
Fexofenadine—Palpitations—Doxorubicin—liver cancer	0.00127	0.00494	CcSEcCtD
Fexofenadine—Anaphylactic shock—Epirubicin—liver cancer	0.00127	0.00493	CcSEcCtD
Fexofenadine—Infection—Epirubicin—liver cancer	0.00126	0.0049	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—liver cancer	0.00125	0.00488	CcSEcCtD
Fexofenadine—Tachycardia—Epirubicin—liver cancer	0.00124	0.00481	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—liver cancer	0.00122	0.00476	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—liver cancer	0.00119	0.00465	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—liver cancer	0.00117	0.00456	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—liver cancer	0.00116	0.00453	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00115	0.00449	CcSEcCtD
Fexofenadine—Insomnia—Epirubicin—liver cancer	0.00114	0.00446	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—liver cancer	0.00114	0.00445	CcSEcCtD
Fexofenadine—Dyspnoea—Epirubicin—liver cancer	0.00113	0.00439	CcSEcCtD
Fexofenadine—Somnolence—Epirubicin—liver cancer	0.00113	0.00438	CcSEcCtD
Fexofenadine—Dyspepsia—Epirubicin—liver cancer	0.00111	0.00434	CcSEcCtD
Fexofenadine—Fatigue—Epirubicin—liver cancer	0.00109	0.00425	CcSEcCtD
Fexofenadine—Pain—Epirubicin—liver cancer	0.00108	0.00422	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00107	0.00416	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—liver cancer	0.00106	0.00413	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—liver cancer	0.00104	0.00407	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—liver cancer	0.00104	0.00405	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Epirubicin—liver cancer	0.00103	0.00403	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—liver cancer	0.00103	0.00401	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—liver cancer	0.00101	0.00393	CcSEcCtD
Fexofenadine—Urticaria—Epirubicin—liver cancer	0.00101	0.00392	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—liver cancer	0.001	0.0039	CcSEcCtD
Fexofenadine—Abdominal pain—Epirubicin—liver cancer	0.001	0.0039	CcSEcCtD
Fexofenadine—Body temperature increased—Epirubicin—liver cancer	0.001	0.0039	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000957	0.00373	CcSEcCtD
Fexofenadine—Hypersensitivity—Epirubicin—liver cancer	0.000932	0.00363	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—liver cancer	0.00093	0.00362	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—liver cancer	0.000926	0.00361	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—liver cancer	0.000926	0.00361	CcSEcCtD
Fexofenadine—Asthenia—Epirubicin—liver cancer	0.000908	0.00354	CcSEcCtD
Fexofenadine—Pruritus—Epirubicin—liver cancer	0.000895	0.00349	CcSEcCtD
Fexofenadine—Diarrhoea—Epirubicin—liver cancer	0.000866	0.00337	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—liver cancer	0.000863	0.00336	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—liver cancer	0.00084	0.00327	CcSEcCtD
Fexofenadine—Dizziness—Epirubicin—liver cancer	0.000837	0.00326	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—liver cancer	0.000828	0.00323	CcSEcCtD
Fexofenadine—Vomiting—Epirubicin—liver cancer	0.000805	0.00313	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—liver cancer	0.000801	0.00312	CcSEcCtD
Fexofenadine—Rash—Epirubicin—liver cancer	0.000798	0.00311	CcSEcCtD
Fexofenadine—Dermatitis—Epirubicin—liver cancer	0.000797	0.00311	CcSEcCtD
Fexofenadine—Headache—Epirubicin—liver cancer	0.000793	0.00309	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—liver cancer	0.000774	0.00302	CcSEcCtD
Fexofenadine—Nausea—Epirubicin—liver cancer	0.000752	0.00293	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—liver cancer	0.000744	0.0029	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—liver cancer	0.000738	0.00288	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—liver cancer	0.000738	0.00287	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—liver cancer	0.000734	0.00286	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—liver cancer	0.000696	0.00271	CcSEcCtD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000311	0.000693	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GOT2—liver cancer	0.000307	0.000685	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—TNF—liver cancer	0.000305	0.000681	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—UGDH—liver cancer	0.000305	0.000681	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—ALB—liver cancer	0.000301	0.000671	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTA1—liver cancer	0.000301	0.000671	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NAT2—liver cancer	0.000297	0.000664	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000294	0.000655	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CYP2E1—liver cancer	0.000288	0.000644	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—UGDH—liver cancer	0.000287	0.000641	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—EPT1—liver cancer	0.000287	0.00064	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000286	0.000639	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000286	0.000638	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALDOB—liver cancer	0.000285	0.000637	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000279	0.000624	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—HPGDS—liver cancer	0.000278	0.000621	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000276	0.000617	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000272	0.000607	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CRABP1—liver cancer	0.000272	0.000607	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000272	0.000607	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TAT—liver cancer	0.000272	0.000607	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—EPT1—liver cancer	0.00027	0.000603	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CYCS—liver cancer	0.00027	0.000603	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SHC3—liver cancer	0.000267	0.000595	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GGT1—liver cancer	0.000265	0.000591	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GOT1—liver cancer	0.000265	0.000591	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	0.000262	0.000585	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TAT—liver cancer	0.000256	0.000572	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000252	0.000562	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—F2—liver cancer	0.00025	0.000557	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000249	0.000555	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PSMA4—liver cancer	0.000248	0.000553	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PSMD10—liver cancer	0.000248	0.000553	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000245	0.000547	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GOT2—liver cancer	0.000241	0.000538	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTP1—liver cancer	0.000238	0.000531	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—HPGDS—liver cancer	0.000238	0.000531	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000236	0.000528	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—ALB—liver cancer	0.000236	0.000528	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—HMOX1—liver cancer	0.000235	0.000524	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.00023	0.000514	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYP2E1—liver cancer	0.000227	0.000506	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—PIK3CA—liver cancer	0.000221	0.000494	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000219	0.00049	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTM1—liver cancer	0.000219	0.000488	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.000215	0.000481	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000215	0.000481	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000214	0.000477	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000213	0.000474	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYCS—liver cancer	0.000212	0.000473	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PSMA4—liver cancer	0.000212	0.000473	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PSMD10—liver cancer	0.000212	0.000473	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000211	0.000471	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GOT1—liver cancer	0.000208	0.000465	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GGT1—liver cancer	0.000208	0.000465	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CYP1A1—liver cancer	0.000207	0.000463	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FST—liver cancer	0.000207	0.000462	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000207	0.000462	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GOT2—liver cancer	0.000206	0.00046	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PRKCE—liver cancer	0.000203	0.000454	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ALB—liver cancer	0.000202	0.000451	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000201	0.00045	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000201	0.000449	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000199	0.000445	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.000198	0.000442	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TRIO—liver cancer	0.000197	0.000441	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000195	0.000435	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000194	0.000433	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP2E1—liver cancer	0.000194	0.000433	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—MTHFR—liver cancer	0.000193	0.000431	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.00019	0.000425	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PPARA—liver cancer	0.00019	0.000423	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCR4—liver cancer	0.000189	0.000423	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000188	0.000419	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTP1—liver cancer	0.000187	0.000417	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CPT1B—liver cancer	0.000185	0.000412	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GLUL—liver cancer	0.000185	0.000412	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PRKCE—liver cancer	0.000185	0.000412	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—HMOX1—liver cancer	0.000184	0.000412	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000183	0.000409	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000183	0.000408	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYCS—liver cancer	0.000181	0.000405	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CSF2—liver cancer	0.00018	0.000401	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NR1H4—liver cancer	0.000178	0.000398	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GGT1—liver cancer	0.000178	0.000397	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GOT1—liver cancer	0.000178	0.000397	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000176	0.000392	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000175	0.000391	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTA3—liver cancer	0.000175	0.000391	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CPT1B—liver cancer	0.000174	0.000389	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GLUL—liver cancer	0.000174	0.000389	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTM1—liver cancer	0.000172	0.000383	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.00017	0.00038	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000168	0.000376	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NR1H4—liver cancer	0.000168	0.000375	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA3—liver cancer	0.000165	0.000368	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CSF2—liver cancer	0.000163	0.000364	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYP1A1—liver cancer	0.000163	0.000364	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CG—liver cancer	0.000162	0.000362	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000162	0.000361	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000161	0.00036	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTA4—liver cancer	0.00016	0.000358	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTP1—liver cancer	0.00016	0.000357	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—HMOX1—liver cancer	0.000158	0.000352	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PPARG—liver cancer	0.000157	0.00035	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTA2—liver cancer	0.000156	0.000348	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MTHFR—liver cancer	0.000152	0.000339	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA4—liver cancer	0.000151	0.000337	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTA1—liver cancer	0.000151	0.000336	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.00015	0.000336	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADAM17—liver cancer	0.00015	0.000334	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000149	0.000333	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARA—liver cancer	0.000149	0.000332	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NAT2—liver cancer	0.000149	0.000332	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA2—liver cancer	0.000147	0.000328	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTM1—liver cancer	0.000147	0.000328	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALDOB—liver cancer	0.000143	0.000319	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CD—liver cancer	0.000143	0.000319	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA1—liver cancer	0.000142	0.000317	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—F2—liver cancer	0.000141	0.000315	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALB—liver cancer	0.000141	0.000315	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PSMD10—liver cancer	0.000141	0.000314	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PSMA4—liver cancer	0.000141	0.000314	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NAT2—liver cancer	0.00014	0.000313	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP1A1—liver cancer	0.000139	0.000311	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000137	0.000306	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CRABP1—liver cancer	0.000136	0.000304	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000136	0.000304	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CG—liver cancer	0.000135	0.000301	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALDOB—liver cancer	0.000135	0.0003	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000134	0.000299	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000133	0.000296	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTHFR—liver cancer	0.00013	0.00029	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CRABP1—liver cancer	0.000128	0.000286	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—F2—liver cancer	0.000128	0.000286	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CG—liver cancer	0.000128	0.000285	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARA—liver cancer	0.000127	0.000284	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CB—liver cancer	0.000124	0.000278	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARG—liver cancer	0.000123	0.000275	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CG—liver cancer	0.000123	0.000274	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HPGDS—liver cancer	0.000119	0.000266	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CD—liver cancer	0.000119	0.000265	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000114	0.000255	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HPGDS—liver cancer	0.000112	0.00025	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CD—liver cancer	0.000112	0.00025	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000112	0.00025	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—liver cancer	0.000111	0.000247	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CG—liver cancer	0.000109	0.000243	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCE—liver cancer	0.000109	0.000243	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CD—liver cancer	0.000108	0.000241	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PSMD10—liver cancer	0.000106	0.000237	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PSMA4—liver cancer	0.000106	0.000237	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARG—liver cancer	0.000105	0.000235	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CB—liver cancer	0.000103	0.000231	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF2—liver cancer	0.000103	0.000231	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GOT2—liver cancer	0.000103	0.00023	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	0.000101	0.000226	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PSMA4—liver cancer	0.0001	0.000223	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PSMD10—liver cancer	0.0001	0.000223	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CB—liver cancer	9.77e-05	0.000218	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GOT2—liver cancer	9.72e-05	0.000217	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2E1—liver cancer	9.7e-05	0.000217	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CSF2—liver cancer	9.64e-05	0.000215	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—RAF1—liver cancer	9.62e-05	0.000215	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CD—liver cancer	9.59e-05	0.000214	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—H2AFX—liver cancer	9.5e-05	0.000212	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IL2—liver cancer	9.5e-05	0.000212	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—liver cancer	9.46e-05	0.000211	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CB—liver cancer	9.39e-05	0.00021	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	9.15e-05	0.000204	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2E1—liver cancer	9.14e-05	0.000204	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYCS—liver cancer	9.08e-05	0.000203	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GOT1—liver cancer	8.91e-05	0.000199	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GGT1—liver cancer	8.91e-05	0.000199	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL2—liver cancer	8.63e-05	0.000193	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TERT—liver cancer	8.59e-05	0.000192	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYCS—liver cancer	8.55e-05	0.000191	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GOT1—liver cancer	8.39e-05	0.000187	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GGT1—liver cancer	8.39e-05	0.000187	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CB—liver cancer	8.36e-05	0.000187	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTP1—liver cancer	8e-05	0.000179	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMOX1—liver cancer	7.89e-05	0.000176	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KDR—liver cancer	7.86e-05	0.000175	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK14—liver cancer	7.81e-05	0.000174	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ESR1—liver cancer	7.66e-05	0.000171	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CA—liver cancer	7.58e-05	0.000169	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—F2—liver cancer	7.57e-05	0.000169	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTP1—liver cancer	7.54e-05	0.000168	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMOX1—liver cancer	7.44e-05	0.000166	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—liver cancer	7.35e-05	0.000164	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APC—liver cancer	7.24e-05	0.000162	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CG—liver cancer	7.24e-05	0.000162	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP1A1—liver cancer	6.97e-05	0.000156	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—liver cancer	6.93e-05	0.000155	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BRAF—liver cancer	6.81e-05	0.000152	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP1A1—liver cancer	6.57e-05	0.000147	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTHFR—liver cancer	6.5e-05	0.000145	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARA—liver cancer	6.38e-05	0.000142	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CD—liver cancer	6.37e-05	0.000142	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CA—liver cancer	6.31e-05	0.000141	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SERPINE1—liver cancer	6.3e-05	0.000141	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KRAS—liver cancer	6.23e-05	0.000139	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—liver cancer	6.19e-05	0.000138	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTHFR—liver cancer	6.12e-05	0.000137	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARA—liver cancer	6.01e-05	0.000134	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CA—liver cancer	5.96e-05	0.000133	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CA—liver cancer	5.73e-05	0.000128	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RAF1—liver cancer	5.68e-05	0.000127	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CB—liver cancer	5.55e-05	0.000124	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MTOR—liver cancer	5.55e-05	0.000124	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CG—liver cancer	5.46e-05	0.000122	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HRAS—liver cancer	5.3e-05	0.000118	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARG—liver cancer	5.27e-05	0.000118	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1B—liver cancer	5.21e-05	0.000116	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—liver cancer	5.15e-05	0.000115	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CG—liver cancer	5.15e-05	0.000115	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—liver cancer	5.1e-05	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL2—liver cancer	5.1e-05	0.000114	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CA—liver cancer	5.09e-05	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—liver cancer	5.07e-05	0.000113	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCND1—liver cancer	4.97e-05	0.000111	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARG—liver cancer	4.97e-05	0.000111	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JUN—liver cancer	4.96e-05	0.000111	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CTNNB1—liver cancer	4.92e-05	0.00011	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—liver cancer	4.87e-05	0.000109	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—liver cancer	4.82e-05	0.000108	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1A—liver cancer	4.81e-05	0.000107	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CD—liver cancer	4.8e-05	0.000107	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—liver cancer	4.74e-05	0.000106	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK8—liver cancer	4.69e-05	0.000105	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—liver cancer	4.68e-05	0.000104	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CD—liver cancer	4.52e-05	0.000101	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—liver cancer	4.47e-05	9.97e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—liver cancer	4.33e-05	9.67e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—liver cancer	4.29e-05	9.57e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CB—liver cancer	4.18e-05	9.34e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—liver cancer	4.16e-05	9.29e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MYC—liver cancer	3.98e-05	8.9e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFB1—liver cancer	3.97e-05	8.87e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CB—liver cancer	3.94e-05	8.8e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KRAS—liver cancer	3.68e-05	8.22e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CA—liver cancer	3.38e-05	7.55e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TP53—liver cancer	3.27e-05	7.31e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HRAS—liver cancer	3.13e-05	6.99e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—liver cancer	3e-05	6.69e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—liver cancer	2.76e-05	6.17e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CA—liver cancer	2.55e-05	5.69e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CA—liver cancer	2.4e-05	5.37e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—liver cancer	2.08e-05	4.65e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—liver cancer	1.96e-05	4.38e-05	CbGpPWpGaD
